Dendritic cell-based approaches to cancer immunotherapy

Expert Opinion on Investigational Drugs

Volumn 7, Issue 10, 1998, Pages 1617-1627

  Morse, M A ^a   Lyerly, H K ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

Active immunotherapy; Antigen specific T cells; Dendritic cells; Tumour antigens; Vaccines

Indexed keywords

TUMOR ANTIGEN; TUMOR CELL VACCINE; TUMOR VACCINE;

ACTIVE IMMUNIZATION; ANTIGEN PRESENTING CELL; BIOTECHNOLOGY; CANCER; CANCER IMMUNOTHERAPY; DENDRITIC CELL; HUMAN; IMMUNE SYSTEM; IMMUNITY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; REVIEW;

EID: 0031679792     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.7.10.1617     Document Type: Review

References (87)